Commentary on a multi-institutional analysis of external beam radiotherapy for T1-T2 prostate cancer: "love the one you're with" and "do the right thing".

This publication has 9 references indexed in Scilit:

• A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer.
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate
  Urology, 2003
• Race and Survival of Men Treated for Prostate Cancer on Radiation Therapy Oncology Group Phase III Randomized Trials
  Journal of Urology, 2003
• International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy
  Journal of Clinical Oncology, 2002
• Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer
  Urology, 2001
• Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison
  International Journal of Radiation Oncology*Biology*Physics, 2000
• 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques
  Urology, 1999
• The Correlation Between the Astro Consensus Panel Definition of Biochemical Failure and Clinical Outcome for Patients with Prostate Cancer Treated with External Beam Irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1998